Structure Therapeutics
Structure Therapeutics is a biotech company focused on developing innovative small molecule medicines with a platform that utilizes advanced computational and structure-based drug discovery technologies. The company is advancing a pipeline of treatments for chronic diseases and operates in both the US and China.
Headquarters
South San Francisco, California, United States
Company Size
51-200 employees
Founded
2017
Structure Therapeutics is a biopharmaceutical company with the mission 'Medicine is our platform. Accessibility is our cure.' The company is focused on developing medicines with an emphasis on accessibility, and maintains an active pipeline and team as indicated on its website.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Structure Therapeutics.
20% above the average for this role
Sr. Director/Executive Director, Computational Chemistry
preludetx
Computational Theoretical Chemist III
1910
Associate Director
Revolution Medicines
Senior Scientist - Associate Director, Computational Chemistry
Superluminal Medicines, Inc.
Associate Director Computational Biology, Cardio-Renal-Metabolic diseases
Digital Biology
Scientific Leader, Integrated Medicinal Chemistry, Computational Chemistry, Cheminformatics and DMPK
Relay Therapeutics